EXPO vs GSK · P/E 28, rev $337.9M vs P/E 13, $103.31B cap
Exponent Inc (EXPO) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Exponent Inc (EXPO) is a engineering & construction company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported EXPO revenue for 2026-07-03 was $337.9M. Net income was $59.0M. EXPO currently screens at market cap $2.89B and trailing P/E 27.9.
GSK does not have a complete income-statement cache yet.
EXPO currently screens at market cap $2.89B and trailing P/E 27.9. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the EXPO and GSK stock pages for the full models.
Not investment advice.